Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. reported 3 holdings worth US$177M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 7, 2026
Regeneron Pharmaceuticals, Inc. reported 3 holdings worth US$177M as of Jun 30, 2026. Largest: Parabilis Medicines, Inc., Intellia Therapeutics, Inc. and Adicet Bio, Inc. Filed Aug 7, 2026 (Form 13F).
- Holdings
- 3
- Value as reported
- US$177M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Parabilis Medicines, Inc. | 4.17M | US$114M | 64.4% |
| Intellia Therapeutics, Inc. | 3.7M | US$62.7M | 35.4% |
| Adicet Bio, Inc. | 60,511 | US$523K | 0.30% |